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The fragile X syndrome, one of the most common forms of inherited mental retardation, is caused by
an expansion of a polymorphic CGG repeat upstream the coding region of the FMR1 gene. These expansions
are associated with hypermethylation of the FMR1 gene, which results in the absence of the gene product,
the FMR1 protein (FMRP). The physiological function of FMRP remains to be determined. We studied
the ultrastructural localization of FMRP at the electron microscopical level using the immunogold technique.
FMRP is associated with ribosomes attached to the endoplasmic reticulum and with ribosomes free in the
cytoplasm. In addition, FMRP is found in the nucleus where the protein is associated with the granular
component of the nucleolus. The cellular function of FMRP is hypothesized in relation to its subcellular
distribution. q 1996 Academic Press, Inc.
Fragile X syndrome is characterized by a large variability in clinical presentation, including
mental retardation, macroorchidism and facial abnormalities as the main characteristics in
affected males1. The most common mutation found in fragile X patients is an unstable expansion
of a CGG repeat in the first exon of the FMR1 gene2-4. This expansion in patients results in
hypermethylation of the CpG island in front of the FMR1 gene and as a consequence no
transcription and thus no translation of the FMR1 gene occurs5-7. The absence of functional
FMR1 Protein (FMRP), the protein product of the FMR1 gene, is the primary defect of the
fragile X syndrome8,9.
FMRP is expressed in many tissues with the most abundant expression in specific neurons
of the central nervous system and in early spermatogonia8-12. Immunocytochemical studies at
the light microscopic level have shown that FMRP is found predominantly in the cytoplasm8,9.
However, in some studies a nuclear localization of the protein in specific cell types have been
reported8,13. One of these studies reported a nuclear localization for one isoform of FMRP in
transfected COS-cells using a construct that exclude exon 14 of the FMR1 gene13.
FMRP contains two KH domains and an RGG box14,15. Both sequence motifs are present in
many RNA binding proteins. RNA binding properties of FMRP has been demonstrated too14,15.
RNA binding studies in cells from a fragile X patient with a missense mutation in one of the two
KH domains resulted in FMRP with reduced RNA binding capacity, which is consistent with the
hypothesis that RNA binding is essential in mediating FMRP function16-18.
Additional to its RNA binding capacity an association in vitro with ribosomes has recently
been described and it has been suggested that this binding occurs via rRNA19-20. However, all
these results were obtained solely by in vitro studies. An in vivo RNA target(s) or other cellular
components for FMRP has not been identified, yet.
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Since, the specific function of FMRP in the cell is still poorly understood, we investigated
the subcellular distribution of FMRP. Here, we describe the in vivo association with cellular
structures of FMRP in transfected COS-cells. Our immunoelectron microscopic studies illus-
trate that FMRP is associated with free ribosomes and with ribosomes that are attached to the
membrane of the endoplasmic reticulum. Furthermore, we show that FMRP is already present
in the granular component of the nucleolus, which contains maturing ribosomal precursor
particles.
MATERIALS AND METHODS
DNA constructs. A 3,765 cDNA clone of FMR1 was cloned in the EcoRI site of the eukaryotic expression vector
pSG523. In this construct the expression of FMRP is controlled by the SV40 promoter. The construct contains a b-
globin intron and a polyadenylation signal. Transfections with this construct will result in a protein of 74 kDa8. The
FMR1 missing exon 14 clone was generated as described before 13 and the construct was cloned in the expression
vector pcDNAI/AMP (Invitrogen), which is controlled by the CMV promotor.
Transfections. COS-cells were cultured in 1X DMEM / 10% FCS at 377C and 10% CO2 . Cells were seeded and
cultured for 24 hours. Transfections were performed as described in the protocol provided with the lipofectamine
reagent (Gibco-BRL), for transfections 2 mg DNA and 20 ml lipofectamine were used per 21104 seeded cells. After
transfection the cells were cultured for 48 hours. Subsequently, cells used for light microscopy were transferred to
coverslips and cultured for another 24 hours. Cells used for electronmicroscopy were fixed 72 hours after transfection.
Immunocytochemistry. For light microscopy, cells were fixed in 0.1 M phosphate buffered saline (PBS) containing
3% paraformaldehyde (pH 7.3) for 10 minutes at room temperature followed by a permeabilization step in 100%
methanol for 20 minutes. FMRP was localized using an indirect immunoperoxidase technique. In the first step we
used a monoclonal antibody against FMRP9 and in the second step a rabbit anti-mouse immunoglobulins conjugated
with peroxidase (DAKO) was applied. Enzyme activity was visualized using DAB (Sigma) as substrate. Endogenous
peroxidase activity was blocked by pre-treatment of the cells with 3% H2O2 after the permeabilization step. Cells
were counterstained with Heamatoxylin and mounted with aquamount.
For electronmicroscopy, cells were fixed in 0.1 M PBS, containing 1% acrolein and 0.4% glutaraldehyde for 1
hour at room temperature. Subsequently, cells were embedded in Lowicryl K4M according to a standard protocol24.
Ultrathin sections were cut with a LKB Nova ultratome and immuno-incubated for FMRP with the monoclonal
antibody9. Antigen-antibody complexes were visualized using a second incubation step with goat anti-mouse immuno-
globulins conjugated with 10 nm colloidal gold particles (AURION). Sections were stained with uranylacetate and
leadnitrate and examined in a Philips CM100 at 80 kV.
RESULTS
Thus far, immunocytochemical studies of FMRP in transfected COS-cells were based on
the use of immuno-fluorescence microscopy. The resolution of this technique is limited, which
makes conclusions about association of FMRP with specific cell organelles difficult. Therefore,
in the past only a discrimination between cytoplasmic or nuclear localization could be made.
In a first attempt to enhance the immunocytochemical signal at the light microscopic level,
we used an indirect immunoperoxidase technique to detect FMRP in transfected COS-cells.
Figure 1 shows the FMRP distribution in COS-cells transfected with a full length cDNA
construct and a construct missing exon 14 of the FMR1 gene. Normal FMRP was predominantly
found in the cytoplasm, often in large aggregates. However, in some cells we could detect
FMRP in the nucleus, in close association with the nucleolus (Fig. 1A). In contrast, the cellular
localization of FMRP with the internal deletion of exon 14 revealed predominantly a nuclear
staining, with the exclusion of the nucleolus (Fig. 1B).
FIG. 1. Cellular localization of FMRP, using an indirect immunoperoxidase technique in COS-cells transfected
with a full length cDNA for FMR1 (A) and a construct missing exon 14 sequences of the FMR1 gene (B). The highest
expression of normal FMRP is found in the cytoplasm, but also in the nucleus a clear labelling can be detected. Note
that the reaction product (brown) in the cytoplasm is very often found in large aggregates. The expression of FMRP,
excluding exon 14, shows a different labelling pattern. Most of the reaction product is present in the nucleus and
only a minor fraction was found in the cytoplasm. The reaction product is virtually absent in the nucleolus.
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We performed immunoelectron microscopy to study the subcellular distribution of FMRP
in vivo. The gold particles in Figure 2 illustrate the subcellular localization of FMRP in these
transfected COS-cells. In the cytoplasm, FMRP was associated with ribosomes bound to the
endoplasmic reticulum (ER) membrane (Figs. 2A and 2B) and with ribosomes free in the
cytosol (Fig. 2C). Very often we could observe a concentration of ribosomes close to the ER
membrane. Apparently, these fast dividing COS-cells are active in protein production. This
phenomenon was also seen in COS-cells that were not transfected with FMR1 (Fig. 2D). The
latter suggests that overexpression of FMRP does not play a role in this concentration of
ribosomes. The specificity of the labelling procedure is demonstrated by the absence of gold
particles in COS-cells that were not transfected with FMR1, but completed the transfection
procedure (Fig. 2D).
Interestingly, beside a cytoplasmic localization FMRP could also be demonstrated in the
granular component of the nucleolus (Fig. 2E), which contains maturing ribosomal precursor
particles. The distribution of gold particles in these transfected COS-cells demonstrates that
most of the FMRP is present in the cytoplasm and only a minor fraction is present in the
nucleus.
DISCUSSION
The discovery of the gene defect in the FMR1 gene has led to a better understanding of the
molecular basis of the fragile X mental retardation syndrome. However, the knowledge about
the function of FMRP, the protein product of the FMR1 gene, in the cell is still limited. In
this immunoelectron microscopic study we report the actual in vivo localization of FMRP. We
found FMRP associated with ribosomes that were free in the cytoplasm and with ribosomes
that were attached to the ER membrane. The resolution of our immunocytochemical studies
is not high enough to demonstrate the association of FMRP with the ribosomal 60S subunit
as was suggested by Khandjian et al. on the basis of their in vitro experiments19.
Surprisingly, we could demonstrate the presence of FMRP in the nucleolus where the protein
was associated with the granular component, which contains maturing ribosomal precursor
particles. Since, proteins above the size of 60 kDa can enter the nucleus only in an active
way21 this would implicate that FMRP, on the basis of its molecular weight of 67-80 kDa, is
also dependent on such a signal dependent transport across the nuclear pore. Expression studies
demonstrated that the N-terminus of FMRP (spanning exon 1-8) contains signal(s) or binding
motifs to mediate the protein to the nucleus13. However, the majority of FMRP in the normal
in vivo situation is found in the cytoplasm8,9 (Figure 1A). A possible explanation for this
discrepancy came from studies on an exon 14 splice variant13 (Figure 1B). This splice variant
was found predominantly in the nucleus. It was proposed that a cytoplasmic retention signal
was present within exon 14 of the FMR1 gene. Recently, it was shown that FMRP contains
a nuclear export signal (NES) (Warren, personal communication). They found that sequences
present in exon 14 are able to transport a reporter protein from the nucleus to the cytoplasm.
The presence of both these signals (NLS and NES) suggests that FMRP may shuttle between
the nucleus and the cytoplasm.
FIG. 2. Subcellular localization of FMRP, using an indirect immunogold labelling technique in COS-cells
transfected with a full length cDNA. FMRP is found in association with ribosomes that are bound to the endoplasmic
reticulum membrane (A and B) and in association with free ribosomes in the cytoplasm (C). In these COS-cells we
notice very often a concentration of ribosomes lining the endoplasmic reticulum membrane (arrows in B, C and D).
Note that these aggregates are also found in untransfected cells (D). Furthermore, FMRP is localized in the nucleolus
of transfected cells (E). The arrows indicate the nuclear membrane. LLysosome; MMitochondrion; NNucleus;
CCytoplasm; RRough endoplasmic reticulum; NuNucleolus.
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These observations and our data that FMRP is present in the nucleolus would argue for the
hypothesis that after synthesis in the cytoplasm active transport of FMRP to the nucleus, either
via an NLS or via the interaction of the N-terminus with a nuclear component, takes place.
In the nucleus an association with maturing ribosomal precursor particles, located in the
nucleolus, occurs. It remains unclear whether FMRP plays an active role in targeting ribosomal
precursor particles out of the nucleus or that FMRP is a just a ribosomal protein leaving the
nucleus in a passive way, mediated by maturing ribosomal particles. The latter is most likely,
since in cells from fragile X patients, lacking FMRP, a normal transport of ribosomes from
the nucleus to the cytoplasm occurs.
On the other hand, the RNA binding properties of FMRP and the in vitro association with
ribosomes led to different proposals for a theoretical function for FMRP. One possibility is that
FMRP plays a regulatory role in the translational machinery of proteins by mediating transport of
mRNA. There are two arguments against this hypothesis. First, our finding that FMRP is associated
with the nucleolus, indicating a binding to rRNA instead of mRNA. Second, the fact that the small
ribosomal subunit first binds a mRNA molecule and subsequently associates with the large ribo-
somal subunit, which makes the association of FMRP with the large ribosomal subunit secondary
for a role in mRNA binding. In this respect, Tamanini et al.20 already suggested the association
of FMRP with ribosomes via rRNA in their in vitro studies.
Our study suggests a nuclear role for FMRP, like the many ribosomal proteins that are
imported from the cytoplasm and subsequent packaged into ribonucleoprotein particles. Indeed,
FMRP shuttles between the nucleus and the cytoplasm. In both compartments FMRP is bound
to ribosomes, which is characteristic for ribosomal proteins. Although ribosomes contain a
large number of proteins, the function of many of them is unknown. It is thought that they
enhance the function of the ribosomes.
However, in this view it is difficult to explain that the absence of widely expressed FMRP
causes the ‘‘limited’’ clinical features observed in fragile X syndrome. The identification of
two human genes, FXR1 and FXR2, which show a high homology with the FMR1 gene shed
a new light on a possible function of FMRP. Both, FXR1 and FXR2, can form homo- and
heteromultimers with FMRP and like FMRP they also have RNA binding properties. Interest-
ingly, FXR1 is not expressed in human brain22 (Hoogeveen, unpublished results). Perhaps the
impossibility of FXR2 protein to form heteromultimers in vivo by the absence of FMRP and
FXR1 proteins in neurons from affected males is responsible for the mental retardation in
these patients. Alternatively, a misrouting of the FXR2 protein because of the lack of FMRP
expression and subsequent targeting to the nucleus and/or out of the nucleus may cause the
dysfunction of central nervous system neurons.
Clearly, extensive studies to validate this hypothesis are necessary. The biochemical basis
for the interaction between FMRP and the two homologs FXR1 and FXR2 and the in vivo
RNA target(s) for FMRP are just two examples of further investigations. The answers to these
questions may result in more knowledge about the cellular function of FMRP and the underlying
cause of the characteristic phenotype of the fragile X syndrome.
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